TRADING UPDATES: Avacta raises funds; Orcadian ends development deal
5th Oct 2026 20:21
(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Monday and not separately reported by Alliance News: Read More
| Price | 68.50p on 06-10-2026 at 16:45:07 |
|---|---|
| Change | -4.00p -5.56% |
| Buy | 69.00p |
| Sell | 68.00p |
| Last Trade: | Unknown 228,417.00 at 68.00p |
| Day's Volume: | 4,698,642 |
| Last Close: | 68.00p |
| Open: | 68.50p |
| ISIN: | GB00BYYW9G87 |
| Day's Range | 67.50p - 68.50p |
| 52wk Range: | 49.00p - 90.50p |
| Market Capitalisation: | £310.73m |
| VWAP: | 67.76049p |
| Shares in Issue: | 456.96m |
Sector: Medicine and Biotech
Listed In: FTSE AIM All-Share,
Avacta Group (AVCT) Latest Trades |
||||
| Buy/Sell | Volume | Trade Prc | Trade Type | Trade Time |
|---|---|---|---|---|
| Unknown* | 228,417 | 68.00p | OTC Trade |
17:09:20 - 06-Oct-26 |
| Sell* | 100,000 | 67.6625p | Ordinary |
16:43:01 - 06-Oct-26 |
| Sell* | 15,000 | 68.00p | Ordinary |
16:39:11 - 06-Oct-26 |
| Sell* | 34,016 | 68.00p | Uncrossing Trade |
16:35:18 - 06-Oct-26 |
| Sell* | 3,000 | 68.00p | Ordinary |
16:29:59 - 06-Oct-26 |
| Buy* | 100 | 69.00p | Ordinary |
16:29:21 - 06-Oct-26 |
| Sell* | 1,470 | 68.00p | Ordinary |
16:28:12 - 06-Oct-26 |
| Sell* | 14,862 | 68.00p | Ordinary |
16:27:28 - 06-Oct-26 |
| Sell* | 367 | 68.00p | Ordinary |
16:25:43 - 06-Oct-26 |
| Sell* | 5,000 | 68.22p | Ordinary |
16:23:07 - 06-Oct-26 |
Avacta Group (AVCT) Regulatory News |
||
| Date | Source | Headline |
|---|---|---|
| 5th Oct 2026 4:22 pm | RNS | Proposed Fundraise to raise approximately £12.5m |
| 30th Sep 2026 7:30 am | RNS | Capital Access Window - Avacta Group Plc |
| 30th Sep 2026 7:01 am | RNS | Capital Access Window |
| 30th Sep 2026 7:00 am | RNS | Interim Results for Six Months to June 30, 2026 |
| 25th Sep 2026 8:00 am | RNS-R | pre|CISION® Platform Wins R&D Achievement Award |
| 25th Sep 2026 7:00 am | RNS | Further Demonstration of Potential of AVA6103 |
| 16th Sep 2026 7:00 am | RNS | Clinical Proof of Mechanism for preCISION Platform |
| 14th Sep 2026 7:00 am | RNS | Mats Blom to Board as Chair of Audit Committee |
| 4th Sep 2026 7:00 am | RNS | Accelerated Payment Convertible Bond Installment |
| 1st Sep 2026 7:00 am | RNS | Share Option Awards to Management Team at Avacta |